Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Drug Modeling Softwares Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Drug Modeling Softwares Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Database
    • 1.3.3 Software
    • 1.3.4 Others
  • 1.4 Market by Application
    • 1.4.1 Global Drug Modeling Softwares Market Share by Application: 2020 VS 2026
    • 1.4.2 Drug Discovery and Development
    • 1.4.3 Computational Physiological Medicine
    • 1.4.4 Disease Modelling
    • 1.4.5 Medical Imaging
    • 1.4.6 Predictive Analysis of Drug Targets
    • 1.4.7 Simulation Software
    • 1.4.8 Cellular Simulation
    • 1.4.9 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Drug Modeling Softwares Market Perspective (2015-2026)
  • 2.2 Drug Modeling Softwares Growth Trends by Regions
    • 2.2.1 Drug Modeling Softwares Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Drug Modeling Softwares Historic Market Share by Regions (2015-2020)
    • 2.2.3 Drug Modeling Softwares Forecasted Market Size by Regions (2021-2026)
  • 2.3 Drug Modeling Softwares Industry Dynamic
    • 2.3.1 Drug Modeling Softwares Market Trends
    • 2.3.2 Drug Modeling Softwares Market Drivers
    • 2.3.3 Drug Modeling Softwares Market Challenges
    • 2.3.4 Drug Modeling Softwares Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Drug Modeling Softwares Players by Market Size
    • 3.1.1 Global Top Drug Modeling Softwares Players by Revenue (2015-2020)
    • 3.1.2 Global Drug Modeling Softwares Revenue Market Share by Players (2015-2020)
  • 3.2 Global Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Drug Modeling Softwares Revenue
  • 3.4 Global Drug Modeling Softwares Market Concentration Ratio
    • 3.4.1 Global Drug Modeling Softwares Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drug Modeling Softwares Revenue in 2019
  • 3.5 Key Players Drug Modeling Softwares Area Served
  • 3.6 Key Players Drug Modeling Softwares Product Solution and Service
  • 3.7 Date of Enter into Drug Modeling Softwares Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Modeling Softwares Breakdown Data by Type

  • 4.1 Global Drug Modeling Softwares Historic Market Size by Type (2015-2020)
  • 4.2 Global Drug Modeling Softwares Forecasted Market Size by Type (2021-2026)

5 Drug Modeling Softwares Breakdown Data by Application

  • 5.1 Global Drug Modeling Softwares Historic Market Size by Application (2015-2020)
  • 5.2 Global Drug Modeling Softwares Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Drug Modeling Softwares Market Size (2015-2026)
  • 6.2 North America Drug Modeling Softwares Market Size by Type (2015-2020)
  • 6.3 North America Drug Modeling Softwares Market Size by Application (2015-2020)
  • 6.4 North America Drug Modeling Softwares Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Drug Modeling Softwares Market Size (2015-2026)
  • 7.2 Europe Drug Modeling Softwares Market Size by Type (2015-2020)
  • 7.3 Europe Drug Modeling Softwares Market Size by Application (2015-2020)
  • 7.4 Europe Drug Modeling Softwares Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug Modeling Softwares Market Size (2015-2026)
  • 8.2 Asia-Pacific Drug Modeling Softwares Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Drug Modeling Softwares Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Drug Modeling Softwares Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Drug Modeling Softwares Market Size (2015-2026)
  • 9.2 Latin America Drug Modeling Softwares Market Size by Type (2015-2020)
  • 9.3 Latin America Drug Modeling Softwares Market Size by Application (2015-2020)
  • 9.4 Latin America Drug Modeling Softwares Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug Modeling Softwares Market Size (2015-2026)
  • 10.2 Middle East & Africa Drug Modeling Softwares Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Drug Modeling Softwares Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Drug Modeling Softwares Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 JSR Corporation(Crown Bioscience)
    • 11.1.1 JSR Corporation(Crown Bioscience) Company Details
    • 11.1.2 JSR Corporation(Crown Bioscience) Business Overview
    • 11.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Introduction
    • 11.1.4 JSR Corporation(Crown Bioscience) Revenue in Drug Modeling Softwares Business (2015-2020))
    • 11.1.5 JSR Corporation(Crown Bioscience) Recent Development
  • 11.2 Chemical Computing Group ULC
    • 11.2.1 Chemical Computing Group ULC Company Details
    • 11.2.2 Chemical Computing Group ULC Business Overview
    • 11.2.3 Chemical Computing Group ULC Drug Modeling Softwares Introduction
    • 11.2.4 Chemical Computing Group ULC Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.2.5 Chemical Computing Group ULC Recent Development
  • 11.3 Nimbus Therapeutics
    • 11.3.1 Nimbus Therapeutics Company Details
    • 11.3.2 Nimbus Therapeutics Business Overview
    • 11.3.3 Nimbus Therapeutics Drug Modeling Softwares Introduction
    • 11.3.4 Nimbus Therapeutics Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.3.5 Nimbus Therapeutics Recent Development
  • 11.4 Schrodinger, Inc
    • 11.4.1 Schrodinger, Inc Company Details
    • 11.4.2 Schrodinger, Inc Business Overview
    • 11.4.3 Schrodinger, Inc Drug Modeling Softwares Introduction
    • 11.4.4 Schrodinger, Inc Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.4.5 Schrodinger, Inc Recent Development
  • 11.5 Genedata AG
    • 11.5.1 Genedata AG Company Details
    • 11.5.2 Genedata AG Business Overview
    • 11.5.3 Genedata AG Drug Modeling Softwares Introduction
    • 11.5.4 Genedata AG Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.5.5 Genedata AG Recent Development
  • 11.6 Biognos AB
    • 11.6.1 Biognos AB Company Details
    • 11.6.2 Biognos AB Business Overview
    • 11.6.3 Biognos AB Drug Modeling Softwares Introduction
    • 11.6.4 Biognos AB Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.6.5 Biognos AB Recent Development
  • 11.7 Compugen Ltd
    • 11.7.1 Compugen Ltd Company Details
    • 11.7.2 Compugen Ltd Business Overview
    • 11.7.3 Compugen Ltd Drug Modeling Softwares Introduction
    • 11.7.4 Compugen Ltd Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.7.5 Compugen Ltd Recent Development
  • 11.8 Dassault Systemes
    • 11.8.1 Dassault Systemes Company Details
    • 11.8.2 Dassault Systemes Business Overview
    • 11.8.3 Dassault Systemes Drug Modeling Softwares Introduction
    • 11.8.4 Dassault Systemes Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.8.5 Dassault Systemes Recent Development
  • 11.9 Acellera
    • 11.9.1 Acellera Company Details
    • 11.9.2 Acellera Business Overview
    • 11.9.3 Acellera Drug Modeling Softwares Introduction
    • 11.9.4 Acellera Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.9.5 Acellera Recent Development
  • 11.10 Instem(Leadscope)
    • 11.10.1 Instem(Leadscope) Company Details
    • 11.10.2 Instem(Leadscope) Business Overview
    • 11.10.3 Instem(Leadscope) Drug Modeling Softwares Introduction
    • 11.10.4 Instem(Leadscope) Revenue in Drug Modeling Softwares Business (2015-2020)
    • 11.10.5 Instem(Leadscope) Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
    Market Analysis and Insights: Global Drug Modeling Softwares Market
    The global Drug Modeling Softwares market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Modeling Softwares market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Modeling Softwares market in terms of revenue.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Modeling Softwares market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Modeling Softwares market.
    Drug Modeling Softwares Breakdown Data by Type
    Database
    Software
    Others
    Drug Modeling Softwares Breakdown Data by Application
    Drug Discovery and Development
    Computational Physiological Medicine
    Disease Modelling
    Medical Imaging
    Predictive Analysis of Drug Targets
    Simulation Software
    Cellular Simulation
    Others
    Based on regional and country-level analysis, the Drug Modeling Softwares market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    In the competitive analysis section of the report, leading as well as prominent players of the global Drug Modeling Softwares market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The following players are covered in this report:
    JSR Corporation(Crown Bioscience)
    Chemical Computing Group ULC
    Nimbus Therapeutics
    Schrodinger, Inc
    Genedata AG
    Biognos AB
    Compugen Ltd
    Dassault Systemes
    Acellera
    Instem(Leadscope)
    Buy now